Genetic forms of hypopituitarism and their manifestation in the neonatal period
Introduction
The pituitary gland is a central regulator of growth, metabolism, reproduction and homeostasis. The mature gland consists of the adenohypophysis, which comprises the anterior and the later involuting intermediate lobe, and the neurohypophysis or posterior lobe. The anterior pituitary is populated by five different cell types producing six different hormones: somatotrophs (growth hormone, GH), thyrotrophs (thyrotrophin or thyroid stimulating hormone, TSH), lactotrophs (prolactin, PRL), gonadotrophs (follicle-stimulating hormone, FSH and luteinizing hormone, LH) and corticotrophs (corticotrophin or adrenocorticotrophic hormone, ACTH). The intermediate lobe contains melanotrophs producing pro-opiomelanocortin (POMC), which is the precursor to melanocyte-stimulating hormone (MSH) and endorphins. The posterior lobe of the pituitary consists of the axonal projections of neurons, the cell bodies of which reside in the hypothalamus and secrete arginine vasopressin (AVP) (supraoptic nuclei) and oxytocin (paraventricular nuclei).
The development of the pituitary gland depends on the sequential temporal and spatial expression of transcription factors and signalling molecules. Congenital hypopituitarism is the deficiency in one or more pituitary hormones, and may be caused by mutations in any of the genes involved in pituitary development (Table 1). It manifests either as an isolated hormone deficiency, the commonest being isolated growth hormone deficiency (IGHD), or combined pituitary hormone deficiencies (CPHD) when two or more pituitary hormones are affected. In some patients, the hormonal deficits may present as part of a syndrome with patients manifesting abnormalities in structures that share a common embryological origin with the pituitary gland, such as the eye and forebrain. As a general rule, mutations in genes implicated in the early stages of development of the pituitary tend to result in syndromic forms of hypopituitarism in association with extra-pituitary defects and midline abnormalities. On the other hand, mutations in genes required for the specification of particular cell types or encoding specific hormone subunits give rise to isolated pituitary hormone deficiencies. The clinical features of hypopituitarism are variable both in severity and time of presentation and onset may be in the neonatal period or evolve later in life [1], [2].
Section snippets
Embryology of the pituitary gland
The pituitary gland has a dual embryonic origin: the anterior and intermediate lobes are derived from the oral ectoderm whilst the posterior pituitary is derived from the neural ectoderm. The development of the gland occurs in a well defined sequence of events that has been studied extensively in the mouse and reflects that in humans [3]. These include the formation of (i) the pituitary placode, (ii) the rudimentary Rathke's pouch, (iii) the definitive Rathke's pouch and (iv) the adult
Hypopituitarism with spine abnormalities (LHX3)
Expression of the LIM homeobox 3 (Lhx3) gene is detected in the developing nervous system and Rathke's pouch and persists in the adult pituitary gland. It is one of the earliest markers for cells that are destined to form the anterior and intermediate lobes and its continued expression is essential for the formation of gonadotrophs, thyrotrophs, somatotrophs and lactotrophs [13]. Mice with a targeted homozygous disruption of Lhx3 die shortly after birth and exhibit pituitary aplasia, suggesting
Mutations in PROP1
Prop1 is a member of the paired-like family of homeodomain transcription factors. It is first expressed within Rathke's pouch at E10, in a region overlapping the expression domain of Hesx1. Expression peaks at E12 throughout the pouch and is then markedly decreased and restricted until E15.5 when it disappears [60]. Prop1 can act as both a transcriptional repressor (for Hesx1 expression) or a transcriptional activator [for expression of Pou1f1 (Pit-1)] [60], [61]. On the other hand,
Isolated hormone deficiencies
Congenital isolated GH deficiency (IGHD) has a reported incidence of 1:4000–1:10,000 live births, with most cases being sporadic. There are four described familial forms of IGHD, that account for 5–30% of cases [78], [79] (Table 2). Congenital IGHD may result from mutations in the genes encoding growth hormone (GH1) or the growth hormone releasing hormone receptor (GHRHR), from mutations within transcription factors SOX3 and HESX1, or it may be the presenting symptom in some cases of CPHD [2],
Clinical manifestations of congenital hypopituitarism in neonates
Neonates with congenital hypopituitarism may present with non-specific symptoms, with or without associated developmental defects such as ocular, midline and genital abnormalities. Alternatively, they may be initially asymptomatic but at risk of developing pituitary hormone deficiencies over time. For example neonates with optic nerve hypoplasia, midline abnormalities or syndromes known to be associated with hypopituitarism will need, in the first instance, assessment of their endocrine status,
Assessment of the HPA axis
As ACTH deficiency and the resulting hypocortisolism can be life threatening, it is important to establish if the hypothalamo-pituitary-adrenal axis is intact. However, this can be quite challenging, especially in asymptomatic neonates with midline defects who are at risk of developing ACTH deficiency. During the first six months of life the circadian rhythm of cortisol excretion has not yet been established, baseline morning versus evening samples are not conclusive and treatment with steroids
The role of magnetic resonance imaging
Magnetic resonance imaging (MRI) of the brain and pituitary is important for the work-up of neonates with suspected or diagnosed hypopituitarism, as there is a correlation between the neuro-radiological abnormalities and the severity and evolution of the endocrinopathy [84]. Signs to look for include the size of the anterior pituitary, the presence and location of the posterior pituitary (absent or ectopic/undescended), the presence and morphology of the infundibulum, the presence and
Management and follow-up of neonates with diagnosed/suspected hypopituitarism
Neonates diagnosed with congenital hypopituitarism require life long follow-up by a multidisciplinary team. The aim is to (a) optimize hormone replacement therapy, (b) monitor for evolving hormone deficiencies, (c) address the complex needs of patients with syndromic hypopituitarism and SOD, including visual assessment and neurodevelopmental support, and (d) offer genetic counseling in cases where a genetic defect has been detected. The mainstay of treatment is replacement therapy with
References (106)
- et al.
The hypothalamic–pituitary axis: co-development of two organs
Curr Opin Cell Biol
(1996) - et al.
Early steps in pituitary organogenesis
Trends Genet
(1999) - et al.
Roles of the LHX3 and LHX4 LIM-homeodomain factors in pituitary development
Mol Cell Endocrinol
(2007) - et al.
Signaling and epigenetic regulation of pituitary development
Curr Opin Cell Biol
(2007) - et al.
Mechanisms underlying pituitary hypoplasia and failed cell specification in Lhx3-deficient mice
Dev Biol
(2008) - et al.
Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4
Am J Hum Genet
(2001) - et al.
Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism
Best Pract Res Clin Endocrinol Metab
(2008) - et al.
Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England
J Pediatr
(2006) - et al.
SOX genes and neural progenitor identity
Curr Opin Neurobiol
(2005) - et al.
Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism
Am J Hum Genet
(2005)
Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency
Am J Hum Genet
Increased gene dosage at Xq26–q27 is associated with X-linked hypopituitarism
Genomics
Downstream of Otx2, or how to get a head
Trends Genet
Heterozygous mutations of OTX2 cause severe ocular malformations
Am J Hum Genet
Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination
Cell
Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis
J Biol Chem
Anterior pituitary hormone effects on hepatic functions in infants with congenital hypopituitarism
Ann Hepatol
Hypopituitarism oddities: congenital causes
Horm Res
Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter?
Clin Endocrinol (Oxf)
Multistep control of pituitary organogenesis
Science
Early development of the pituitary gland: induction and shaping of Rathke's pouch
Rev Endocr Metab Disord
Signaling and transcriptional mechanisms in pituitary development
Annu Rev Neurosci
Molecular physiology of pituitary development: signaling and transcriptional networks
Physiol Rev
Formation of Rathke's pouch requires dual induction from the diencephalon
Development
The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism
Ann Med
Specification of pituitary cell lineages by the LIM homeobox gene Lhx3
Science
Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss
Hum Mol Genet
Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation
J Clin Endocrinol Metab
Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency
Nat Genet
Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency
J Clin Endocrinol Metab
Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia
Development
Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies
J Clin Endocrinol Metab
A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica
Endocr J
Functional relationship between LHX4 and POU1F1 in light of the LHX4 mutation identified in patients with pituitary defects
J Clin Endocrinol Metab
Septo-optic dysplasia — novel insights into the aetiology
Horm Res
Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia
J Pediatr Endocrinol Metab
Genetics of septo-optic dysplasia
Pituitary
Role of transcription factors in midline central nervous system and pituitary defects
Endocr Dev
Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis
Genes Dev
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse
Nat Genet
Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain
Development
Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism
Dis Model Mech
Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia
Hum Mol Genet
HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism
J Clin Endocrinol Metab
SOX3 is required during the formation of the hypothalamo-pituitary axis
Nat Genet
Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome
Hum Mol Genet
SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies
Am J Med Genet
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans
J Clin Invest
SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development
J Clin Endocrinol Metab
Cited by (110)
Evidence-Based Neonatology: Neonatal Pituitary Hormone Deficiencies
2023, Principles of NeonatologyCentral Endocrine Complications Among Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
2023, International Journal of Radiation Oncology Biology PhysicsGonadotrophin Hormones
2022, The PituitaryAnterior Pituitary Failure
2022, The PituitaryPituitary abnormalities in midline brain defects
2020, EClinicalMedicineDisorders of Childhood Growth
2020, Sperling Pediatric Endocrinology: Expert Consult - Online and Print